CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 72 of 72 entries

View as:

A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine

Phase: N/A Priority: Normal

NCT ID: NCT00001994 Org: User:

Start: - End: - Due: -

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00008554 Org: User:

Start: 11/30/00 End: - Due: -

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00005663 Org: User:

Start: 06/30/99 End: - Due: -

A Study of 1592U89 in HIV-Infected Adults

Phase: N/A Priority: Normal

NCT ID: NCT00002200 Org: User:

Start: - End: - Due: -

Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure

Phase: N/A Priority: Normal

NCT ID: NCT00002047 Org: User:

Start: - End: - Due: -

A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002286 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of 935U83 in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002338 Org: User:

Start: - End: - Due: -

A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia

Phase: N/A Priority: Normal

NCT ID: NCT00001991 Org: User:

Start: - End: - Due: -

A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002390 Org: User:

Start: - End: - Due: -

3TC (Lamivudine; GR109714X) Open-Label Program

Phase: N/A Priority: Normal

NCT ID: NCT00002108 Org: User:

Start: - End: - Due: -

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Phase: N/A Priority: Normal

NCT ID: NCT00002199 Org: User:

Start: - End: - Due: -

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00005017 Org: User:

Start: - End: - Due: -

A Study of Two Anti-HIV Drug Combinations

Phase: N/A Priority: Normal

NCT ID: NCT00002203 Org: User:

Start: - End: - Due: -

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Phase: N/A Priority: Normal

NCT ID: NCT00004981 Org: User:

Start: - End: - Due: -

An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2

Phase: N/A Priority: Normal

NCT ID: NCT00002023 Org: User:

Start: - End: - Due: -

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00002389 Org: User:

Start: - End: - Due: -

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00009061 Org: User:

Start: 11/30/00 End: - Due: -

The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002404 Org: User:

Start: - End: - Due: -

Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)

Phase: N/A Priority: Normal

NCT ID: NCT00002063 Org: User:

Start: - End: - Due: -

A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002000 Org: User:

Start: - End: - Due: -

A Comparison of 141W94 and Indinavir in HIV-Infected Patients

Phase: N/A Priority: Normal

NCT ID: NCT00002202 Org: User:

Start: - End: - Due: -

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Phase: N/A Priority: Normal

NCT ID: NCT00002440 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine	NCT00001994	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy	NCT00008554	Glaxo Wellcome	user2@example.com	None	2000-11-30	-	-	-	-	2025-07-14
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients	NCT00005663	Glaxo Wellcome	user2@example.com	None	1999-06-30	-	-	-	-	2025-07-14
A Study of 1592U89 in HIV-Infected Adults	NCT00002200	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure	NCT00002047	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients	NCT00002286	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of 935U83 in HIV-Infected Patients	NCT00002338	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia	NCT00001991	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients	NCT00002390	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
3TC (Lamivudine; GR109714X) Open-Label Program	NCT00002108	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.	NCT00002199	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment	NCT00005017	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of Two Anti-HIV Drug Combinations	NCT00002203	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)	NCT00004981	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2	NCT00002023	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs	NCT00002389	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs	NCT00009061	Glaxo Wellcome	user2@example.com	None	2000-11-30	-	-	-	-	2025-07-14
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients	NCT00002404	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)	NCT00002063	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients	NCT00002000	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Comparison of 141W94 and Indinavir in HIV-Infected Patients	NCT00002202	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs	NCT00002440	Glaxo Wellcome	user2@example.com	None	-	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance